The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot study of NY-ESO-1c259 T cells in subjects with advanced myxoid/round cell liposarcoma (NCT02992743).
 
Sandra P. D'Angelo
Consulting or Advisory Role - Amgen; EMD Serono; Nektar
 
Mihaela Druta
Consulting or Advisory Role - Eisai; Lilly
Speakers' Bureau - Eisai; Lilly
 
George D. Demetri
Leadership - Blueprint Medicines
Stock and Other Ownership Interests - Bessor Pharma; Blueprint Medicines; Caris Life Sciences; Champions Oncology; G1 Therapeutics; N-of-One
Consulting or Advisory Role - Adaptimmune; Bayer; Blueprint Medicines; Caris Life Sciences; Daiichi Sankyo; Eisai; EMD Serono; G1 Therapeutics; Genocea Biosciences; Janssen Oncology; Kolltan Pharmaceuticals; Kyocera; Lilly; Nektar; Novartis; Pfizer; PharmaMar; Polaris; Sanofi; WIRB-Copernicus Group; ZIOPHARM Oncology
Research Funding - Abbvie (Inst); Janssen Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Patent on use of imatinib for GIST, receive minor royalty payment from Dana-Farber after license between Dana-Farber and Novartis
 
David A. Liebner
Patents, Royalties, Other Intellectual Property - MatchTX LLC
 
Scott Schuetze
Honoraria - EMD Serono; EMD Serono; Janssen Research & Development
Consulting or Advisory Role - EMD Serono; EMD Serono; Janssen Research & Development
Research Funding - AB Science (Inst); Amgen (Inst); BioMed Valley Discoveries (Inst); CytRx Corporation (Inst); Janssen Research & Development (Inst); Lilly (Inst); Plexxikon (Inst); Threshold Pharmaceuticals (Inst); ZIOPHARM Oncology (Inst)
 
Arun S. Singh
No Relationships to Disclose
 
Neeta Somaiah
Consulting or Advisory Role - Bayer
 
Brian Andrew Van Tine
Consulting or Advisory Role - Caris Life Sciences; CytRx Corporation; EMD Serono; Johnson & Johnson; Lilly/ImClone; Novartis; Threshold Pharmaceuticals
Speakers' Bureau - Caris Life Sciences; Johnson & Johnson; Lilly; Novartis
 
Breelyn A. Wilky
Consulting or Advisory Role - Janssen Oncology; Lilly; Novartis
Research Funding - Agenus; ArQule; Daiichi Sankyo; Merck Sharp & Dohme; Novartis
Travel, Accommodations, Expenses - Advenchen Laboratories; Lilly; Novartis
 
Karen Chagin
Employment - Adaptimmune; Johnson & Johnson
Stock and Other Ownership Interests - Adaptimmune; GlaxoSmithKline; Johnson & Johnson
 
Tim Pulham
Employment - Adaptimmune
 
Malini Iyengar
Employment - Adaptimmune
 
Elliot Norry
Employment - Adaptimmune; GlaxoSmithKline
Stock and Other Ownership Interests - Adaptimmune; GlaxoSmithKline
 
Arundathy N. Bartlett-Pandite
Employment - Adaptimmune; GlaxoSmithKline
Stock and Other Ownership Interests - Adaptimmune; GlaxoSmithKline
 
Rafael G. Amado
Employment - Adaptimmune; GlaxoSmithKline
Stock and Other Ownership Interests - Adaptimmune; GlaxoSmithKline